This course develops the technical judgment needed to establish analytical procedure suitability, verify compendial methods, transfer procedures between laboratories, and manage specifications and atypical results using applicable FDA, USP, and ICH requirements.
Why Take This Course
Analytical procedures underpin decisions about pharmaceutical quality, stability, and product acceptance. Their reliability depends on more than successful validation experiments. Instrument qualification, system suitability, compendial requirements, method performance, and laboratory conditions all influence whether analytical results are suitable for their intended purpose. These considerations become particularly important when established procedures are verified, transferred between laboratories, or used to support regulatory submissions.
This course connects analytical method validation, verification, and transfer with the supporting controls required throughout the analytical procedure lifecycle. Participants will examine FDA and USP requirements, ICH guidance, chromatographic system suitability, instrument qualification, and the selection of appropriate validation characteristics. The modules also address alternative procedures, analytical transfer approaches, specifications, and the evaluation of out-of-specification and out-of-trend results. Practical examples and case studies help participants connect technical requirements with laboratory decisions, from initial method assessment through continued use and regulatory compliance.
Key Areas Covered
Specification setting, OOS investigations, and OOT evaluation
Analytical procedure lifecycle and continued method suitability
Analytical method transfer approaches between laboratories
Compendial analytical method verification and suitability factors
Analytical method validation characteristics and performance assessment
Analytical instrument qualification, including DQ, IQ, OQ, PQ
Compendial harmonization and chromatographic system suitability requirements
FDA regulatory requirements and USP compendial approval processes
Course Agenda
MODULE 1:
Seminar objectives review, expectations and scope.
Drug Approval Process and Regulatory (FDA) Requirements (private standards)
Pharmacopeias and Compendial (USP) Approval Process (public standards)
MODULE 2:
Compendial Harmonization Process
Chromatography System Suitability Requirements
Allowed Adjustments of Chromatographic System Parameters
MODULE 3:
Analytical Instrument Qualifications
Instrument Categories
Qualification Phases (DQ, IQ, OQ, PQ)
MODULE 4:
Analytical Method Validation (typical validation parameters)
Specificity
Precision/Accuracy
Linearity/Range
LOD and LOQ
MODULE 5:
Analytical Method Verification
FDA and USP Requirements
Factors to Consider
MODULE 6:
Analytical Method Transfer
Different Approaches
MODULE 7:
Analytical Procedure Life Cycle
MODULE 8:
Setting Specifications FDA regulations and ICH guidelines (Q6A)
Out-of-Specification (OOS)
Out of Trend (OOT)
How to handle OOS and OOT?
Who Should Attend
Quality Assurance Departments
Quality Control Departments
Analytical Development
Regulatory Affairs Departments
Analytical Chemists
Formulation Chemists
Validation Departments
Laboratory Supervisors and Managers
Pharmaceutical Scientists
Kelly Thomas has over two decades of hands-on cGMP experience in pharmaceutical and medical device manufacturing. Her expertise spans quality systems and validation activities, including analytical test methods, equipment, automated processes, computerized systems, and 21 CFR Part 11. She has managed complex industry projects using risk-based approaches and practical quality management principles across regulated manufacturing environments.